# \[e-drug\] WHO Publication: Safety Monitoring of Medicinal Products

**URL:** https://talk.edrugplus.org/t/e-drug-who-publication-safety-monitoring-of-medicinal-products/37064
**Category:** e-drug
**Created:** [March 16, 2012, 4:32pm UTC](https://talk.edrugplus.org/t/e-drug-who-publication-safety-monitoring-of-medicinal-products/37064 "2012-03-16T16:32:41Z")
**Posts on this page:** 1
**Page:** 1

<div class="post-metadata">

### Author: ![pals](https://avatars.discourse-cdn.com/v4/letter/p/9fc348/32.png) [@pals](https://talk.edrugplus.org/u/pals)
#### Post date: [March 16, 2012, 4:32pm UTC](https://talk.edrugplus.org/t/e-drug-who-publication-safety-monitoring-of-medicinal-products/37064/1 "2012-03-16T16:32:41Z")

</div>

E-DRUG: WHO Publication: Safety Monitoring of Medicinal Products - Reporting system for the general public  
---------------------------------------

Dear Colleagues,

A new WHO publication by the title: Safety Monitoring of Medicinal  
Products - Reporting system for the general public

is now available on the WHO website:  
[http://www.who.int/medicines/areas/quality\_safety/safety\_efficacy/EMP\_Co](http://www.who.int/medicines/areas/quality_safety/safety_efficacy/EMP_Co)  
nsumerReporting\_web\_v2.pdf [repair link if broken]

This document aims to provide practical guidelines on how to set up  
national systems for consumers to report adverse reactions to medicines.  
(Throughout this document, the phrase "consumer reporting" is used to  
refer to reporting of adverse drug reactions (ADRs) by the general  
public.)

The creation of a handbook for consumer reporting of ADRs was discussed  
and requested at the thirty-first meeting of the National  
Pharmacovigilance Centres held in Uppsala, Sweden from 20-23 October  
2008, and the development of this publication has been incorporated into  
the aims of the Seventh Framework Programme of the Research Directorate  
of the European Commission and its project Monitoring Medicines  
([http://www.monitoringmedicines.org/](http://www.monitoringmedicines.org/)).

Dr Shanthi Pal  
Pharmacovigilance Programme Manager  
Quality Assurance and Safety: Medicines  
Department of Essential Medicines and Health Products  
World Health Organization  
Geneva, Switzerland  
Tel: + 41 22 791 1318  
E-mail: pals@who.int  
Website: [http://www.who.int/medicines](http://www.who.int/medicines)